Carboxypeptidase B2/CPB2 Antibody (OTI3D5) [PE]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-70444PE
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunohistochemistry, Immunohistochemistry-Paraffin
Label
PE (Excitation = 488 nm, Emission = 575 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # OTI3D5
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for Carboxypeptidase B2/CPB2 Antibody (OTI3D5) [PE]
Immunogen
Human recombinant protein fragment corresponding to amino acids 224-423 of human CPB2(NP_001863) produced in E.coli.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for Carboxypeptidase B2/CPB2 Antibody (OTI3D5) [PE]
Application
Recommended Usage
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Carboxypeptidase B2/CPB2
Alternate Names
CPB2, CPU, TAFI
Gene Symbol
CPB2
Additional Carboxypeptidase B2/CPB2 Products
Product Documents for Carboxypeptidase B2/CPB2 Antibody (OTI3D5) [PE]
Product Specific Notices for Carboxypeptidase B2/CPB2 Antibody (OTI3D5) [PE]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...